Indapamid Ratiopharm (Indapamide)

Indapamide blocks the sodium‑chloride transporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urine output, decreased plasma volume, and lower peripheral vascular resistance, which together lower blood pressure and relieve fluid overload.

The specific dose of Indapamid Ratiopharm is determined by the prescribing healthcare professional based on the patient’s condition, response, and renal function. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

The safety of indapamide in pregnancy and lactation has not been definitively established. It is generally classified as a drug of unknown risk, and it should only be used if the potential benefit justifies any possible risk to the fetus or infant. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering a longer duration of action and a more favorable metabolic profile compared with traditional thiazide diuretics. It provides effective blood‑pressure control with a lower incidence of hypokalemia, making it a preferred option for patients who need sustained antihypertensive therapy and diuresis.

Indapamid Ratiopharm tablets should be stored at room temperature, below 25 °C. Keep them in the original blister pack or container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

The medication is taken orally, usually once daily in the morning, with or without food, as directed by the prescriber. Swallow the tablet whole with a full glass of water and do not crush or chew it unless instructed otherwise.

Serious risks include severe dehydration, electrolyte imbalances such as hyponatremia or hypokalemia, acute kidney injury, and rare allergic reactions like angioedema or Stevens‑Johnson syndrome. Patients should report symptoms such as rapid weight loss, muscle weakness, severe dizziness, or rash to their healthcare provider promptly.

Indapamid Ratiopharm is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide-derived drugs, severe renal impairment, anuria, or those with uncontrolled electrolyte disturbances. Caution is also advised for individuals with gout, diabetes, or hepatic disease, and it should be avoided in pregnancy unless clearly needed.